C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2004
12/22/2004	CN1181509C Electromagnetic device and high-voltage generating device and method of producing electromagnetic device
12/22/2004	CN1181204C Method for preparing 2-hydroxy 4-methylthio butyric acid using nitrilase
12/22/2004	CN1181203C Bt gene with high toxicity to Lepidoptera and Coleoptera insects, expression vector and engineering bacteria
12/22/2004	CN1181202C Bacillus thuringiensis cryl gene, gene combination and expression vector
12/22/2004	CN1181201C LAG-3 splice variants
12/22/2004	CN1181199C Lichenized bacillus L-25 keratinase and its encoding DNA
12/22/2004	CN1181196C Alpha -1,4-glucan lyase from fungus, purifying, gene clone and expression in microbe thereof
12/22/2004	CN1181098C Monoclonal antibody to alpha 2-macroglobulin and its use for detecting glucan
12/22/2004	CN1181097C Monochain antibody with dual specificities possessing activity for restraining adherence and aggregation of blood platelets
12/22/2004	CN1181093C Extraction of integral membrane proteins
12/22/2004	CN1180847C Ejecting pneumatic gene gun
12/22/2004	CN1180843C Polyepitope vaccines
12/21/2004	US6833494 Insulator construct for controlling leaky expression of a lethal gene from enhancing functions of a strong constitutive promoter present in the said Insulator construct following integration into the genome of a plant
12/21/2004	US6833493 Comprises nucleotide sequences coding thioredoxin h protein for improving baking quality of cereal flour; neutralization of venomons; food processing
12/21/2004	US6833492 Nitrogen transport metabolism
12/21/2004	US6833491 Modification of polysaccharides
12/21/2004	US6833490 Involves decreasing the intracellular availability of trehalose-6-phosphate by plant cell transformation with a gene encoding trehalose-6-phosphate phosphatase from E. coli
12/21/2004	US6833489 Assays for modulators of prolyl-4-hydroxylase
12/21/2004	US6833449 Improvements in the coding sequence for foreign genes to be expressed in the cells of higher plants
12/21/2004	US6833446 Plant polynucleotide sequences encoding transcription factors that are components of the cellular transcription apparatus and the use of such polynucleotide sequences in the modification of gene expression
12/21/2004	US6833441 Compositions and methods for generating chimeric heteromultimers
12/21/2004	US6833440 Membrane protein for use in the diagnosis and treatment of nervous system, psychological, vision and brain disorders
12/21/2004	US6833439 IP-10/MIG receptor designated CXCR3, nucleic acids and methods of use therefor
12/21/2004	US6833437 Complement receptor type 1 (CR1)-like sequences
12/21/2004	US6833382 Streptogramins and method for preparing same by mutasynthesis
12/21/2004	US6833355 Use of protein H as cytostatic agent
12/21/2004	US6833348 Inhibiting apoptosis mediated by CD3 T-cell receptor or Fas/Fas-L systems; stimulating lymphocyte activity
12/21/2004	US6833269 Stem cell culture product
12/21/2004	US6833268 Produced in response to immunization with any desired antigen
12/21/2004	US6833265 Proteases from gram-positive organisms
12/21/2004	US6833264 Hyaluronan synthase gene and uses therof
12/21/2004	US6833263 AveC gene product from Streptomyces hygroscopicus
12/21/2004	US6833261 Such as serine proteases from Bacillus for use in cleaning compositions
12/21/2004	US6833258 Process for producing transglutaminase
12/21/2004	US6833257 Fluorimetric detection system of a nucleic acid
12/21/2004	US6833254 Method to identify IRES elements
12/21/2004	US6833253 Nucleotide sequences coding polypeptides for use in the prevention of microorganismal infections
12/21/2004	US6833252 A DNA sequence that can be incorporated in cloning and expression vectors, transformed cell lines and transgenic animals; the vectors are useful in gene mapping and site-directed insertion of genes
12/21/2004	US6833248 Polypeptides; culture product
12/21/2004	US6833245 Methods for screening for transdominant effector peptides and RNA molecules
12/21/2004	US6833243 For diagnosis of psychosis/schizophrenia via detection of mutant allele
12/21/2004	US6833240 Nucleotide sequences coding polypeptide for use in the treatment of cardiovascular disease
12/21/2004	US6833239 Methods to identify modulators of FKHL7 DNA-binding activity
12/21/2004	US6833135 DNA integration into “Mycobacterium spp.” genome by trans-complementation using a site-specific integration system
12/21/2004	US6833132 Method of stimulating epithelial cells using keratinocyte growth factor (KGF) and method of inhibiting KGF activity
12/21/2004	US6833130 Recombinant microorganisms expressing an oligosaccharide receptor mimic
12/21/2004	CA2140649C Hybrid oligonucleotide phosphorothioates
12/21/2004	CA2114788C Synthetic storage proteins with defined structure containing programmable levels of essential amino acids for improvement of the nutritional value of plants
12/16/2004	WO2004108965A1 Methods and reagents for quantitative analysis of dehalococcoides species
12/16/2004	WO2004108964A1 Differentially regulated hepatocellular carcinoma genes and uses thereof
12/16/2004	WO2004108962A1 Method of quantifying nucleic acid transferred into cell and localized in target organelle
12/16/2004	WO2004108961A1 Therapeutic and diagnostic means for papillomas and other diseases involving ped/pea-15
12/16/2004	WO2004108955A1 Methods of identifying compounds which modulate granulocite-colony stimulating factor (g-csf) dependent processes by modulation of the levels of a suppressor of cytokine signaling (socs)
12/16/2004	WO2004108953A1 Method of diagnosing cancer and method of judging cancer risk
12/16/2004	WO2004108945A2 Oligonucleotide modulation of cell adhesion
12/16/2004	WO2004108943A1 Methods and kits for mass production of dsrna
12/16/2004	WO2004108940A2 Viral genome vectors
12/16/2004	WO2004108939A2 Bav packaging regions and e1 transcriptional control regions
12/16/2004	WO2004108938A2 Peptide ligands of dendritic cells for nucleic acid vector targeting
12/16/2004	WO2004108937A1 Cell surface expression vector of sars virus antigen and microorganisms transformed thereby
12/16/2004	WO2004108936A1 Flavivirus replicon packaging system
12/16/2004	WO2004108935A1 Novel vector
12/16/2004	WO2004108934A1 Safe production of a product of interest in hybrid seeds
12/16/2004	WO2004108933A1 A coumermycin/novobiocin-regulated gene expression system
12/16/2004	WO2004108932A1 Bacteria with increased levels of protein secretion, nucleotide sequences coding for a seca protein with increased levels of protein secretion, and method for producing proteins
12/16/2004	WO2004108931A1 Cytokinin receptor ahk3 involved in senescence regulation of plant and use thereof
12/16/2004	WO2004108930A1 Genes participating in fgf signal transduction
12/16/2004	WO2004108929A1 REGULATION OF THE EXPRESSION OF HIGH-AFFINITY IgE RECEPTOR β CHAIN
12/16/2004	WO2004108928A1 Cholesterol biosynthesis pathway modulators and uses thereof
12/16/2004	WO2004108927A1 Laminin 5b
12/16/2004	WO2004108926A1 Methods and kits for propagating and evolving nucleic acids and proteins
12/16/2004	WO2004108925A1 Method for sequentially isolating dna and rna from the same nucleic acid-containing sample
12/16/2004	WO2004108924A1 Cd9/cd81 double-null nonhuman animal
12/16/2004	WO2004108923A1 Cd47 partal peptdie and anti-shps-1 monoclonal antibody
12/16/2004	WO2004108921A1 Method of nucleic acid infusion
12/16/2004	WO2004108920A1 Method of screening anti-obestic medicine, and obesity model animal
12/16/2004	WO2004108915A1 Fusion protein containing a dimerisation domain and an autotransporter domain
12/16/2004	WO2004108909A1 Composition for stabilizing survival of transplanted hematopoietic stem cell, kit for obtaining the composition, method of stabilizing survivial of transplanted hematopoietic stem cell, human monoclonal antibody or human polyclonal antibody and method of producing the same, gene encoding human monoclonal antibody and transf
12/16/2004	WO2004108906A2 Bacterial carriers for nucleotide sequences coding for active substances
12/16/2004	WO2004108904A2 Porcine cmp-n-acetylneuraminic acid hydroxylase gene
12/16/2004	WO2004108903A2 Plant transformation and selection
12/16/2004	WO2004108900A2 Plant transcriptional regulators of disease resistance
12/16/2004	WO2004108897A2 Sirna libraries
12/16/2004	WO2004108894A2 Methods and compositions for amino acid production
12/16/2004	WO2004108893A2 Cell specific replication-competent viral vectors comprising a self processing peptide cleavage site
12/16/2004	WO2004108890A2 Dilute methanol -or ethanol- induced production of polypeptides in microorganisms
12/16/2004	WO2004108889A2 Hybrid antibodies
12/16/2004	WO2004108840A2 Nucleotides for prevention and treatment of bacterial and fungal pathologies
12/16/2004	WO2004108761A2 Canine ghrh gene, polypeptides and methods of use
12/16/2004	WO2004108760A2 Improved secretion of neublastin
12/16/2004	WO2004108756A2 Sars coronavirus peptides and uses thereof
12/16/2004	WO2004108755A2 Chimeric adenovirus capsid proteins
12/16/2004	WO2004108741A1 Process for the concentration and/or isolation of nucleic acid or nucleic acid-containing species
12/16/2004	WO2004108635A2 Mixed zeaxanthin ester concentrate and uses thereof
12/16/2004	WO2004108353A2 Integrated tool with interchangeable wet processing components and automated calibration systems
12/16/2004	WO2004108260A2 Devices and methods for biomaterial production
12/16/2004	WO2004108166A1 Epas1 gene transfer to improve cell therapy
12/16/2004	WO2004108158A1 De-immunized anti-cd3 antibody
12/16/2004	WO2004108078A2 Rationally designed antibodies
12/16/2004	WO2004108071A2 Targeting polypeptides to the central nervous system

1 ... 2114 2115 2116 2117 2118 2119 2120 2121 2122 2123 2124 2125 2126 2127 2128 2129 2130 2131 2132 2133 2134 ... 4023